These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26020439)

  • 1. Three-dimensional Dynamic Contrast-enhanced US Imaging for Early Antiangiogenic Treatment Assessment in a Mouse Colon Cancer Model.
    Wang H; Hristov D; Qin J; Tian L; Willmann JK
    Radiology; 2015 Nov; 277(2):424-34. PubMed ID: 26020439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-Animal Comparison between Three-dimensional Molecularly Targeted US and Three-dimensional Dynamic Contrast-enhanced US for Early Antiangiogenic Treatment Assessment in Colon Cancer.
    Wang H; Lutz AM; Hristov D; Tian L; Willmann JK
    Radiology; 2017 Feb; 282(2):443-452. PubMed ID: 27490690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenografts.
    Pöschinger T; Renner A; Eisa F; Dobosz M; Strobel S; Weber TG; Brauweiler R; Kalender WA; Scheuer W
    Invest Radiol; 2014 Jul; 49(7):445-56. PubMed ID: 24598441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional ultrasound molecular imaging of angiogenesis in colon cancer using a clinical matrix array ultrasound transducer.
    Wang H; Kaneko OF; Tian L; Hristov D; Willmann JK
    Invest Radiol; 2015 May; 50(5):322-9. PubMed ID: 25575176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Three-Dimensional Dynamic Contrast-Enhanced Ultrasound Imaging: First-In-Human Pilot Study in Patients with Liver Metastases.
    El Kaffas A; Sigrist RMS; Fisher G; Bachawal S; Liau J; Wang H; Karanany A; Durot I; Rosenberg J; Hristov D; Willmann JK
    Theranostics; 2017; 7(15):3745-3758. PubMed ID: 29109773
    [No Abstract]   [Full Text] [Related]  

  • 6. Early prediction of tumor response to bevacizumab treatment in murine colon cancer models using three-dimensional dynamic contrast-enhanced ultrasound imaging.
    Zhou J; Zhang H; Wang H; Lutz AM; El Kaffas A; Tian L; Hristov D; Willmann JK
    Angiogenesis; 2017 Nov; 20(4):547-555. PubMed ID: 28721500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of angiogenesis in rabbit orthotropic liver tumors using three-dimensional dynamic contrast-enhanced ultrasound compared with two-dimensional DCE-US.
    Zheng Q; Zhang JC; Wang Z; Ruan SM; Li W; Pan FS; Chen LD; Zhang YC; Wu WX; Xie XY; Lu MD; Shan QY; Wang W
    Jpn J Radiol; 2019 Oct; 37(10):701-709. PubMed ID: 31401722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic contrast-enhanced micro-CT on mice with mammary carcinoma for the assessment of antiangiogenic therapy response.
    Eisa F; Brauweiler R; Hupfer M; Nowak T; Lotz L; Hoffmann I; Wachter D; Dittrich R; Beckmann MW; Jost G; Pietsch H; Kalender WA
    Eur Radiol; 2012 Apr; 22(4):900-7. PubMed ID: 22071777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of Using Volumetric Contrast-Enhanced Ultrasound with a 3-D Transducer to Evaluate Therapeutic Response after Targeted Therapy in Rabbit Hepatic VX2 Carcinoma.
    Kim J; Kim JH; Yoon SH; Choi WS; Kim YJ; Han JK; Choi BI
    Ultrasound Med Biol; 2015 Dec; 41(12):3131-9. PubMed ID: 26365926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma.
    Marzola P; Degrassi A; Calderan L; Farace P; Nicolato E; Crescimanno C; Sandri M; Giusti A; Pesenti E; Terron A; Sbarbati A; Osculati F
    Clin Cancer Res; 2005 Aug; 11(16):5827-32. PubMed ID: 16115922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenic and radiation therapy: early effects on in vivo computed tomography perfusion parameters in human colon cancer xenografts in mice.
    Ren Y; Fleischmann D; Foygel K; Molvin L; Lutz AM; Koong AC; Jeffrey RB; Tian L; Willmann JK
    Invest Radiol; 2012 Jan; 47(1):25-32. PubMed ID: 22178893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absolute quantification of regional renal blood flow in swine by dynamic contrast-enhanced magnetic resonance imaging using a blood pool contrast agent.
    Lüdemann L; Nafz B; Elsner F; Grosse-Siestrup C; Meissler M; Kaufels N; Rehbein H; Persson PB; Michaely HJ; Lengsfeld P; Voth M; Gutberlet M
    Invest Radiol; 2009 Mar; 44(3):125-34. PubMed ID: 19151609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55).
    Pysz MA; Foygel K; Rosenberg J; Gambhir SS; Schneider M; Willmann JK
    Radiology; 2010 Aug; 256(2):519-27. PubMed ID: 20515975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced ultrasound parametric maps to evaluate intratumoral vascularization.
    Pitre-Champagnat S; Leguerney I; Bosq J; Peronneau P; Kiessling F; Calmels L; Coulot J; Lassau N
    Invest Radiol; 2015 Apr; 50(4):212-7. PubMed ID: 25275834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardization of dynamic contrast-enhanced ultrasound for the evaluation of antiangiogenic therapies: the French multicenter Support for Innovative and Expensive Techniques Study.
    Lassau N; Chapotot L; Benatsou B; Vilgrain V; Kind M; Lacroix J; Cuinet M; Taieb S; Aziza R; Sarran A; Labbe C; Gallix B; Lucidarme O; Ptak Y; Rocher L; Caquot LM; Chagnon S; Marion D; Luciani A; Uzan-Augui J; Koscielny S
    Invest Radiol; 2012 Dec; 47(12):711-6. PubMed ID: 23095862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparametric characterization of response to anti-angiogenic therapy using USPIO contrast-enhanced MRI in combination with dynamic contrast-enhanced MRI.
    Kim J; Kim E; Euceda LR; Meyer DE; Langseth K; Bathen TF; Moestue SA; Huuse EM
    J Magn Reson Imaging; 2018 Jun; 47(6):1589-1600. PubMed ID: 29205621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal perfusion 3-T MR imaging: a comparative study of arterial spin labeling and dynamic contrast-enhanced techniques.
    Wu WC; Su MY; Chang CC; Tseng WY; Liu KL
    Radiology; 2011 Dec; 261(3):845-53. PubMed ID: 22095996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uninterpretable Dynamic Susceptibility Contrast-Enhanced Perfusion MR Images in Patients with Post-Treatment Glioblastomas: Cross-Validation of Alternative Imaging Options.
    Heo YJ; Kim HS; Park JE; Choi CG; Kim SJ
    PLoS One; 2015; 10(8):e0136380. PubMed ID: 26296086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early effects of low dose bevacizumab treatment assessed by magnetic resonance imaging.
    Gaustad JV; Simonsen TG; Smistad R; Wegner CS; Andersen LM; Rofstad EK
    BMC Cancer; 2015 Nov; 15():900. PubMed ID: 26573613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-angiogenic Effects of Bumetanide Revealed by DCE-MRI with a Biodegradable Macromolecular Contrast Agent in a Colon Cancer Model.
    Malamas AS; Jin E; Zhang Q; Haaga J; Lu ZR
    Pharm Res; 2015 Sep; 32(9):3029-43. PubMed ID: 25840948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.